Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Versant Venture Capital VI LP | 10% Owner | 2024-08-12 | 387,999 | $1.10 | $427.19kSell |
Versant Venture Capital VI LP | 10% Owner | 2024-08-08 | 400,000 | $1.35 | $540.00kSell |
Stephen R. Brady | President and CEO | 2024-07-03 | 35,000 | $2.11 | $73.85kBuy |
Samuel Whiting | Chief Medical Officer | 2024-07-02 | 4,672 | $2.13 | $9.95kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Michelle Dipp | 216.14% | 7,959,182 | $54.92M | Insider |
Richard Aldrich | 141.61% | 5,214,762 | $35.98M | Insider |
Christoph H. Westphal | 122.94% | 4,527,348 | $31.24M | Insider |
Versant Venture Capital VI LP | 95.24% | 3,507,056 | $24.20M | Insider |
Versant Venture Management LLC | 95.24% | 3,507,055 | $24.20M | Institution |
Bessemer Venture Partners VII LP | 64.96% | 2,392,034 | $16.51M | Insider |
Thomas Woiwode | 59.30% | 2,183,788 | $15.07M | Insider |
Versant Vantage II LP | 57.53% | 2,118,644 | $14.62M | Insider |
Longwood Fund LP | 49.96% | 1,839,689 | $12.69M | Insider |
Joshua Makower | 47.97% | 1,766,407 | $12.19M | Insider |